— Know what they know.
Not Investment Advice

VREOF OTC

Vireo Growth Inc.
1W: -15.7% 1M: -12.1% 3M: -2.7% YTD: +1475.1%
$9.49
-0.36 (-3.65%)
 
Weekly Expected Move ±12.6%
$7 $8 $9 $11 $12
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 29 · $363.0M mcap · 19M float · 0.253% daily turnover · Short 21% of daily vol

Cash Flow Trends

Operating Cash Flow
$4M +136.3% ▲
Capital Expenditures
$30M -155.0% ▼
Free Cash Flow
-$26M -19.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$31M -59.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2017FY2018FY2019FY2020FY2025
— Operating Activities —
Net Income-$84K-$139K-$57M-$7M-$68M
Depreciation & Amort.$379$278$4M$1M$22M
Stock-Based Comp.$0$68K$3M$13M$13M
Change in Working Capital$380K-$88K$47M-$20M$2M
Other Non-Cash Items-$427K$79K-$18M$911K$17M
Operating Cash Flow-$131K-$79K-$22M-$11M$4M
— Investing Activities —
Capital Expenditures$0$0-$8M-$8M-$28M
Acquisitions (Net)$0$0$0$0$39M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0-$15M$21M-$2M
Investing Cash Flow$0$0-$23M$13M$9M
— Financing Activities —
Net Debt Issuance$0$0$0$0$18M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$357K$0$43M$16M$0
Financing Cash Flow$357K$0$43M$16M$18M
Net Change in Cash$226K-$79K-$2M$18M$31M
Cash End of Period$228K$132K$8M$27M$122M
Free Cash Flow-$131K-$79K-$30M-$19M-$26M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms